Cargando…

Dihydroartemisinin: from malaria to the treatment of relapsing head and neck cancers

Detalles Bibliográficos
Autores principales:	Pulito, Claudio, Strano, Sabrina, Blandino, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290621/ https://www.ncbi.nlm.nih.gov/pubmed/32566549 http://dx.doi.org/10.21037/atm.2020.03.104

Ejemplares similares

Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients
por: Sacconi, Andrea, et al.
Publicado: (2023)

Metformin: On Ongoing Journey across Diabetes, Cancer Therapy and Prevention
por: Pulito, Claudio, et al.
Publicado: (2013)

Long Non-coding MIR205HG Depletes Hsa-miR-590-3p Leading to Unrestrained Proliferation in Head and Neck Squamous Cell Carcinoma
por: Di Agostino, Silvia, et al.
Publicado: (2018)

Metformin: Metabolic Rewiring Faces Tumor Heterogeneity
por: Cioce, Mario, et al.
Publicado: (2020)

Oral mucositis: the hidden side of cancer therapy
por: Pulito, Claudio, et al.
Publicado: (2020)

CircPVT1: a pivotal circular node intersecting Long Non-Coding-PVT1 and c-MYC oncogenic signals
por: Palcau, Alina Catalina, et al.
Publicado: (2022)

MicroRNAs: short non-coding players in cancer chemoresistance
por: Donzelli, Sara, et al.
Publicado: (2014)

TMPRSS2, a SARS-CoV-2 internalization protease is downregulated in head and neck cancer patients
por: Sacconi, Andrea, et al.
Publicado: (2020)

What biomarkers (if any) for precise medicine?
por: Strano, Sabrina, et al.
Publicado: (2015)

MicroRNA-181a/b: Novel biomarkers to stratify breast cancer patients for PARPi treatment
por: Mori, Federica, et al.
Publicado: (2013)

The miR-205-5p/BRCA1/RAD17 Axis Promotes Genomic Instability in Head and Neck Squamous Cell Carcinomas
por: Valenti, Fabio, et al.
Publicado: (2019)

Metformin-induced metabolic reprogramming of chemoresistant ALDH(bright) breast cancer cells
por: Cioce, Mario, et al.
Publicado: (2014)

The circRNA–microRNA code: emerging implications for cancer diagnosis and treatment
por: Verduci, Lorena, et al.
Publicado: (2019)

Cdx2 Polymorphism Affects the Activities of Vitamin D Receptor in Human Breast Cancer Cell Lines and Human Breast Carcinomas
por: Pulito, Claudio, et al.
Publicado: (2015)

YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting
por: Lo Sardo, Federica, et al.
Publicado: (2018)

Exploiting Long Non-Coding RNAs and Circular RNAs as Pharmacological Targets in Triple-Negative Breast Cancer Treatment
por: Palcau, Alina Catalina, et al.
Publicado: (2023)

Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects
por: Mori, Federica, et al.
Publicado: (2016)

Head and Neck Cancer
por: Psyrri, Amanda, et al.
Publicado: (2009)

Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam
por: Phuc, Bui Quang, et al.
Publicado: (2017)

Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers
por: Ferraiuolo, Maria, et al.
Publicado: (2017)

microRNAs: short non-coding bullets of gain of function mutant p53 proteins
por: Donzelli, Sara, et al.
Publicado: (2014)

The oncogenic role of circPVT1 in head and neck squamous cell carcinoma is mediated through the mutant p53/YAP/TEAD transcription-competent complex
por: Verduci, Lorena, et al.
Publicado: (2017)

Aberrant transcriptional and post-transcriptional regulation of SPAG5, a YAP-TAZ-TEAD downstream effector, fuels breast cancer cell proliferation
por: Canu, Valeria, et al.
Publicado: (2020)

Oncogenic Intra-p53 Family Member Interactions in Human Cancers
por: Ferraiuolo, Maria, et al.
Publicado: (2016)

Chemoradiotherapy for Head and Neck Cancer
por: D’Onofrio, Ida, et al.
Publicado: (2023)

Gender, mutant p53 and PML: A growing “affaire” in tumor suppression and oncogenesis
por: Di Agostino, Silvia, et al.
Publicado: (2013)

Dihydroartemisinin-Piperaquine Treatment of Multidrug Resistant Falciparum and Vivax Malaria in Pregnancy
por: Poespoprodjo, Jeanne Rini, et al.
Publicado: (2014)

Therapeutic efficacy of dihydroartemisinin-piperaquine combination for the treatment of uncomplicated malaria in Ghana
por: Abuaku, Benjamin, et al.
Publicado: (2023)

Dihydroartemisinin‐piperaquine for treating uncomplicated Plasmodium falciparum malaria
por: Zani, Babalwa, et al.
Publicado: (2014)

Probucol dramatically enhances dihydroartemisinin effect in murine malaria
por: Kume, Aiko, et al.
Publicado: (2016)

ID4: a new player in the cancer arena
por: Dell'Orso, Stefania, et al.
Publicado: (2010)

Mir 145/143: tumor suppressor, oncogenic microenvironmental factor or …both?
por: Cioce, Mario, et al.
Publicado: (2016)

Speech therapy in head and neck cancer
por: Rossi, Vaneli Colombo, et al.
Publicado: (2021)

Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Malaria: A Randomized Trial
por: Kamya, Moses R, et al.
Publicado: (2007)

Adherence to Dihydroartemisinin-Piperaquine Treatment among Patients with Uncomplicated Malaria in Northern Ghana
por: Oduro, Abraham Rexford, et al.
Publicado: (2019)

Advances in biomarkers and treatment strategies for HPV-associated head and neck cancer
por: Pan, Cassie, et al.
Publicado: (2018)

miR-181c associates with tumor relapse of high grade osteosarcoma
por: Federica, Mori, et al.
Publicado: (2015)

Dihydroartemisinin Prevents Progression and Metastasis of Head and Neck Squamous Cell Carcinoma by Inhibiting Polarization of Macrophages in Tumor Microenvironment
por: Chen, Ran, et al.
Publicado: (2020)

Targeting mutant p53 in cancer: the latest insights
por: Di Agostino, Silvia, et al.
Publicado: (2019)

Melatonin and Hippo Pathway: Is There Existing Cross-Talk?
por: Lo Sardo, Federica, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_69ee5lje6dgbuf3c1hjmo3o3fu